Skip to main content

8 May 2026

Last updated: Thursday 7 May 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A good beginning in the perilous biotech business

Tuesday 26 October 2010

Interviewee/Contributor

Ingmar Hoerr

Organisation

CureVac GmbH

Organisations

Oryx GmbH & Co KG and Valo Therapeutics Ltd
BioAlliance
Autifony Therapeutics Ltd
Independent healthcare and biotech analyst
Immunicum AB
Kymab Ltd
Forendo Pharma Ltd
Affiris AG
Maxion Therapeutics Ltd
Ilyine Ltd

Interviewees and Contributers

Stéphane Boissel
Steff Taelman
Emanuel Björne
Ayokunmi Ajetunmobi
Ilka Wicke
Nessa Carey
Andrew Sandham
Reinhard Kandera
Paula Salmikangas and Björn Carlsson and Steffen Thirstrup
Christian Hogg

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec appoints COO and CCO

Thursday 23 April 2026

Immunic appoints CNS expert to board

Thursday 16 April 2026

CEPI appoints board members

Thursday 16 April 2026

New CEO at Orano Med

Thursday 16 April 2026

Aravax names two board members

Thursday 16 April 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form